NVCR
Novocure Ltd
14.90$
-6.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 25.2% | 24.3% | 24.3% | 23.0% | 22.8% | 20.8% | 24.9% | 26.1% | 26.8% | 24.2% | 22.4% | 22.4% | 23.9% | |
| 74.8% | 75.7% | 75.7% | 77.0% | 77.2% | 79.2% | 75.1% | 73.9% | 73.2% | 75.8% | 77.6% | 77.6% | 76.1% | |
| 42.1% | 40.6% | 37.3% | 36.5% | 33.5% | 31.8% | 34.7% | 35.2% | 32.3% | 34.9% | 33.5% | 28.0% | 32.1% | |
| 32.9% | 29.5% | 28.5% | 25.1% | 25.9% | 44.9% | 28.9% | 27.7% | 27.5% | 24.7% | 49.3% | 21.7% | 30.7% | |
| 120.5% | 114.3% | 105.7% | 99.3% | 97.9% | 118.5% | 99.6% | 98.8% | 94.8% | 99.0% | 116.4% | 83.4% | 98.2% | |
| -45.7% | -38.7% | -30.0% | -22.4% | -20.7% | -39.3% | -24.4% | -24.9% | -21.5% | -23.2% | -38.7% | -5.8% | -22.1% | |
| – | 6.9% | – | – | – | – | – | – | – | 0.3% | 1.1% | – | – | |
| -37.9% | -28.8% | -22.8% | -15.1% | -13.9% | -34.2% | -19.5% | -22.0% | -18.0% | -23.5% | -39.8% | -6.8% | -21.8% | |
| 1.0% | 6.4% | 5.1% | 7.1% | 5.8% | 6.6% | 2.6% | 3.2% | 4.3% | -9.4% | 1.1% | 1.7% | -0.6% | |
| -38.9% | -35.2% | -28.0% | -22.2% | -19.7% | -40.9% | -22.1% | -25.3% | -22.3% | -14.1% | -40.9% | -8.5% | -21.2% | |
| -35.7% | -26.8% | -20.8% | -13.2% | -12.3% | -6.5% | -17.4% | -19.9% | -15.8% | -19.6% | -36.4% | -5.8% | -19.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.